Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

M&C Saatchi chair to step down

(Sharecast News) - Ad agency M&C Saatchi has announced that its non-exec chair Zillah Byng-Thorne is to step down from the company next month. Byng-Thorne, who joined the board in 2023, said she would step down due to other executive and non-executive commitments and increased regulatory responsibilities.

At M&C Saatchi's annual general meeting on 15 May, she will be replaced by Heather Rabbatts, currently a senior independent director of the company.

Rabbatts is said to hold "extensive experience" in a number of executive and non-executive positions across media, sport, local government and infrastructure.

Commenting on Byng-Thorne's departure, Rabbatts said: "Having joined the company at a crossroads, her enthusiasm and experience has been the driving force behind M&C Saatchi's transformation strategy which was initiated during her time as executive chair.

"We are particularly grateful for her successful leadership, guidance and execution of the strategy in building a future growth model for our stakeholders and our brand which is now primed for the next stage of growth."

M&C Saatchi's share price was down 0.6% lower at 161.5p by 0952 GMT.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.